Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering

Biomaterials

Volumn 33, Issue 9, 2012, Pages 2673-2680

  Patra, Chinmoy ^a   Talukdar, Sarmistha ^b   Novoyatleva, Tatyana ^a   Velagala, Siva R ^a   Mühlfeld, Christian ^c,d   Kundu, Banani ^b   Kundu, Subhas C ^b   Engel, Felix B ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adhesion; Cardiac tissue engineering; Connexin 43; Fibroin; Non mulberry silk; RGD peptide

Indexed keywords

CARDIAC TISSUE ENGINEERING; CONNEXIN 43; FIBROIN; NON-MULBERRY SILK; RGD PEPTIDE;

ADHESION; CELL ADHESION; CELLS; ENGINEERING; HEART; PLANTS (BOTANY); PROTEINS; SILK; THREE DIMENSIONAL; TISSUE;

SCAFFOLDS (BIOLOGY);

FIBRONECTIN; SILK FIBROIN; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL COMMUNICATION; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART; HEART MUSCLE CELL; IN VITRO STUDY; MULBERRY; NONHUMAN; PRIORITY JOURNAL; RAT; SILKWORM; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL CYCLE; FIBROINS; HEART; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, ELECTRON, SCANNING; MOTHS; MYOCYTES, CARDIAC; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ANTHERAEA MYLITTA; BOMBYX MORI; MORUS (ANGIOSPERM); RATTUS;

EID: 84855936932     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.036     Document Type: Article

References (42)

1. van Amerongen M.J., Engel F.B. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. JCell Mol Med 2008, 12:2233-2244.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
3. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006, 12:452-458.
4. Feng Z., Matsumoto T., Nakamura T. Measurements of the mechanical properties of contracted collagen gels populated with rat fibroblasts or cardiomyocytes. JArtif Organs 2003, 6:192-196.
5. Akhyari P., Fedak P.W., Weisel R.D., Lee T.Y., Verma S., Mickle D.A., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002, 106:I137-I142.
6. Radisic M., Yang L., Boublik J., Cohen R.J., Langer R., Freed L.E., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 2004, 286:H507-H516.
7. Radisic M., Park H., Martens T.P., Salazar-Lazaro J.E., Geng W., Wang Y., et al. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. JBiomedical Materials Research Part A 2008, 86:713-724.
8. Boublik J., Park H., Radisic M., Tognana E., Chen F., Pei M., et al. Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng 2005, 11:1122-1132.
9. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
10. Park H., Larson B.L., Guillemette M.D., Jain S.R., Hua C., Engelmayr G.C., et al. The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials 2011, 32:1856-1864.
11. Wang Y., Singh A., Xu P., Pindrus M.A., Blasioli D.J., Kaplan D.L. Expansion and osteogenic differentiation of bone marrow-derived mesenchymal stem cells on a vitamin C functionalized polymer. Biomaterials 2006, 27:3265-3273.
12. Willerth S.M., Sakiyama-Elbert S.E. Combining stem cells and biomaterial scaffolds for constructing tissues and cell delivery. Stembook 2008, doi/10.3824/stembook.1.1.1. L. Girard (Ed.).
13. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
14. Li L., Sabir M.I., Xu X.X. Areview on biodegradable polymeric materials for bone tissue engineering applications. JMater Sci 2009, 44:5713-5724.
15. Omenetto F.G., Kaplan D.L. New opportunities for an ancient material. Science 2010, 329:528-531.
16. Omenetto F.G., Kaplan D.L. SnapShot: silk biomaterials. Biomaterials 2010, 31:6119-6120.
17. Talukdar S., Nguyen Q.T., Chen A.C., Sah R.L., Kundu S.C. Effect of initial cell seeding density on 3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials 2011, 32:8927-8937.
18. Talukdar S., Mandal M., Hutmacher D.W., Russell P.J., Soekmadji C., Kundu S.C. Engineered silk fibroin protein 3D matrices for invitro tumor model. Biomaterials 2011, 32:2149-2159.
19. Bhardwaj N., Nguyen Q.T., Chen A.C., Kaplan D.L., Sah R.L., Kundu S.C. Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for invitro cartilage tissue engineering. Biomaterials 2011, 32:5773-5781.
20. Rockwood D.N., Preda R.C., Yucel T., Wang X., Lovett M.L., Kaplan D.L. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 2011, 6:1612-1631.
21. Mandal B.B., Kundu S.C. Non-bioengineered silk gland fibroin protein: characterization and evaluation of matrices for potential tissue engineering applications. Biotechnol Bioeng 2008, 100:1237-1250.
22. Nazarov R., Jin H.J., Kaplan D.L. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 2004, 5:718-726.
23. Datta A., Ghosh A.K., Kundu S.C. Differential expression of the fibroin gene in developmental stages of silkworm, Antheraea mylitta (Saturniidae). Comp Biochem Physiol B Biochem Mol Biol 2001, 129:197-204.
24. Zhang Y.Q., Zhou W.L., Shen W.D., Chen Y.H., Zha X.M., Shirai K., et al. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates. JBiotechnol 2005, 120:315-326.
25. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., et al. The inflammatory responses to silk films invitro and invivo. Biomaterials 2005, 26:147-155.
26. Engel F.B., Hauck L., Cardoso M.C., Leonhardt H., Dietz R., von Harsdorf R. Amammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ Res 1999, 85:294-301.
27. Mandal B.B., Kundu S.C. Anovel method for dissolution and stabilization of non-mulberry silk gland protein fibroin using anionic surfactant sodium dodecyl sulfate. Biotechnol Bioeng 2008, 99:1482-1489.
28. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
29. Harlow E., Lane D. Staining tissues. Using antibodies: a laboratory manual 1998, 151-220. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. J. Cuddihy, T. Kuhlman (Eds.).
30. Borg T.K., Rubin K., Lundgren E., Borg K., Obrink B. Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev Biol 1984, 104:86-96.
31. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079-1091.
32. Mandal B.B., Das S., Choudhury K., Kundu S.C. Implication of silk film RGD availability and surface roughness on cytoskeletal organization and proliferation of primary rat bone marrow cells. Tissue Eng Part A 2010, 16:2391-2403.
33. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
34. Barczyk M., Carracedo S., Gullberg D. Integrins. Cell Tissue Res 2010, 339:269-280.
35. Engel F.B., Schebesta M., Duong M.T., Lu G., Ren S., Madwed J.B., et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005, 19:1175-1187.
36. Guerrero P.A., Schuessler R.B., Davis L.M., Beyer E.C., Johnson C.M., Yamada K.A., et al. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. JClin Invest 1997, 99:1991-1998.
37. Wollert K.C., Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010, 7:204-215.
38. Ekser B., Cooper D.K. Update: cardiac xenotransplantation. Curr Opin Organ Transplant 2008, 13:531-535.
39. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
40. Acharya C., Ghosh S.K., Kundu S.C. Silk fibroin film from non-mulberry tropical tasar silkworms: a novel substrate for invitro fibroblast culture. Acta Biomater 2009, 5:429-437.
41. Thull R. Surface functionalization of materials to initiate auto-biocompatibilization invivo. Materialwiss Werkst 2001, 32:949-952.
42. Yanagisawa S., Zhu Z., Kobayashi I., Uchino K., Tamada Y., Tamura T., et al. Improving cell-adhesive properties of recombinant Bombyx mori silk by incorporation of collagen or fibronectin derived peptides produced by transgenic silkworms. Biomacromolecules 2007, 8:3487-3492.